or
Bookmark and Share
cDNA encoding a BMP type II receptor
   
Document Number
US Patent 6306622
Issued Date
October 23, 2001
Link
Inventors
Map
Abstract
The present invention relates to an isolated BMP, (bone morphogonic protein) receptor kinase protein or soluble fragment thereof, a DNA sequence coding for the BMP receptor kinase protein or the soluble fragment thereof, a recombinant expression vector comprising the DNA sequence, a host cell comprising the recombinant expression vector, and a method of expressing the BMP receptor kinase protein or soluble fragment thereof.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
31
Comments:
no comments yet
Owner
The Procter & Gamble Co. (Cincinnati, OH)
Published
October 23, 2001
Application Number
08/334,179
Filed
November 4, 1994
US Classification
435/69.1   435/320.1 435/325 435/365 530/350 536/23.1 536/23.5
Int'l Classification
C07K   14/435   (20060101)   C07K   14/71   (20060101)  
Examiner
Assistant Examiner
USPTO Field of Search
530/350   435/69.1   435/320.1   435/325   435/365   536/23.1   536/23.5  
Related Patents
6800440 - Role of PPH1 gene in pulmonary hypertension - Owned by The Trustees of Columbia University in the City of New York (New York, NY)

This invention provides a method of detecting whether a subject is either predisposed to or afflicted with a pulmonary disease which comprises (1) obtaining a suitable sample from the subject; (2) detecting in the sample a bone morphogenetic protein receptor-II mutation which is not present in wildtype bone morphogenetic protein receptor-II, wherein the presence of a mutation indicates that the subject is predisposed to or afflicted with the pulmonary disease. In one embodiment, the pulmonary disease is Familial Primary Pulmonary Hypertension.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us